Factors Associated With Advanced Liver Fibrosis in a Population With Type 2 Diabetes: A Multicentric Study in Mexico City [0.03%]
墨西哥首都一项多中心研究中2型糖尿病人群中与肝纤维化进展相关的因素
Froylan D Martínez-Sánchez,Maria J Corredor-Nassar,Sandra M Feria-Agudelo et al.
Froylan D Martínez-Sánchez et al.
Background and objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease, primarily due to insulin resistance and type 2 diabetes (T2D). Despite the strong link...
Epidemiological Dynamics of Burden and Health Inequalities in Metabolic Dysfunction-associated Steatotic Liver Disease in Adolescents at Global, Regional, and National Levels, 1990-2021 [0.03%]
1990年至2021年青少年与代谢紊乱相关的肝脂肪变性疾病的疾病负担和健康不平等的全球、区域和国家流行病学动态
Xiaohui Sui,Junde Zhao,Yuxin Yang et al.
Xiaohui Sui et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) has become one of the major causes of chronic liver disease among adolescents. However, epidemiological studies on MASLD in adolescents are stil...
Transarterial Chemoembolization: A Consistent and Continuously Evolving Therapy for Hepatocellular Carcinoma [0.03%]
肝癌治疗不断进步与创新的经动脉化疗栓塞疗法
Amar Mukund,Niraj Kumar,Amol Srivastava et al.
Amar Mukund et al.
Since its introduction in 1977, transarterial chemoembolization (TACE) has widely been accepted treatment for unresectable intermediate stage hepatocellular carcinoma (HCC). Conventional TACE (c-TACE) uses an emulsion of chemotherapeutic ag...
Metabolic and Alcohol-associated Liver Disease and its Place in the Spectrum of Steatotic Liver Disease [0.03%]
代谢和酒精相关性肝病及其在脂肪变性肝病谱系中的位置
Stephanie M Rutledge,Gene Y Im
Stephanie M Rutledge
Coronary Artery Disease Does Not Increase Risk of Cardiovascular Events and Mortality One Year After Liver Transplantation [0.03%]
冠心病不会增加肝移植术后一年内心血管事件和死亡的风险
Marco Biolato,Alfonso W Avolio,Luca Miele et al.
Marco Biolato et al.
LTSI Consensus Guidelines: Preoperative Cardiac Evaluation in Adult Liver Transplant Recipients [0.03%]
成人肝移植受者的术前心脏评估LTSI共识指南
Shweta A Singh,Kelika Prakash,Kamal Kajal et al.
Shweta A Singh et al.
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among LT candidates and accounts for up to 40% of the overall mortality within one month. It is influenced by traditional and nontraditional risk factors related t...
Pre-Liver Transplant Cardiac Evaluation-Demystifying the Heart Under Stress or Unclogging the Coronaries? [0.03%]
肝移植前的心脏评估：揭开压力下的心脏面纱还是疏通冠状动脉？
Samriddhi Poyekar,Dharmesh Kapoor
Samriddhi Poyekar
Rajesh Rajalingam,Ashwin Rammohan,Ramkiran Cherukuru et al.
Rajesh Rajalingam et al.
The introduction of minimally invasive donor hepatectomy (MIDH) operation saw the initiation and incorporation of minimal access surgery into the field of liver transplantation (LT). Several studies, meta-analyses, and consensus guidelines ...
Hani S Aboalam,Marwa K Hassan,Nada El-Domiaty et al.
Hani S Aboalam et al.
Wilson disease (WD) is a rare autosomal recessive disorder caused by ATP7B gene mutations, leading to pathological copper accumulation that primarily affects the liver, brain, and eyes. Diagnosing WD remains a significant challenge due to i...
Hepatic Infarct: Uncommon Causes of an Uncommon Vascular Complication Revealed at Nontransplant Medical Autopsies [0.03%]
肝梗死：非移植病理解剖中罕见血管并发症的不常见原因
Dipanwita Biswas,Suvradeep Mitra,Ritambhra Nada et al.
Dipanwita Biswas et al.
Background and aims: Hepatic infarcts are uncommon vascular lesions due to dual vascular supply of the liver characterized by the peripherally-located wedge-shaped large zones of necrosis in the hepatic parenchyma. They a...